Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Regeneron Pharmaceuticals

2 instances of misconduct since 1995 | $44.8M in penalties

Regeneron is a biotechnology company that develops medicines to treat eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, and infectious diseases. Regeneron developed a monoclonal antibody treatment for COVID-19 as part of the U.S. government’s Operation Warp Speed in 2020.

Correspondence Date
FY Rank Contract Awards
2021 #14 $5,565.1M

2 Instances of Misconduct since 1995

3 additional instances of misconduct pending resolution.

Date Instance Penalty
Total  
7/22/2021 Humana v. Regeneron Pharmaceuticals (Eylea Kickbacks)
Regeneron Pharmaceuticals
Pending
10/5/2020 Allele Biotechnology and Pharmaceuticals v. Regeneron
Regeneron Pharmaceuticals
Pending
6/24/2020 Eylea Kickbacks and False Claims
Regeneron Pharmaceuticals
Pending
10/5/2018 Shareholder Derivative Lawsuit
Regeneron Pharmaceuticals
$44,500,000
1/13/2014 Unpaid Excise Tax on Medicine Production
Regeneron Pharmaceuticals
$250,000

Federal Contractor Misconduct Database

Contractor Contact Information

Contractor Links